34th Annual Cardiovascular Interventions

February 27, 2023 — Amarin Corporation plc announced that data evaluating the role of VASCEPA /VAZKEPA (icosapent ethyl) and eicosapentaenoic acid (EPA) in reducing cardiovascular events in at-risk patients will be presented at the joint ACC.23 together with the

February 27, 2023 — CÚRAM SFI Research Centre for Medical Devices researchers have published in Nature Communications a key study establishing a new pre-clinical model to develop clinically relevant treatments for heart attacks.  

February 24, 2023 — Medtronic today announced the relaunch of its Harmony Transcatheter Pulmonary Valve (TPV) System, a minimally invasive alternative to open-heart surgery for congenital heart disease patie

February 24, 2023 — As the American College of Cardiology (ACC) prepares to commence its 72nd Scientific Session, “ACC23 Together with WCC” (ACC23/WCC), March 4-6 in New Orleans, La.  — women’s cardiovascular health and health equity are emerging as a prominent topic, in scientific sessions, late-breaking clinical trials and keynote addresses.

February 23, 2023 — Few adverse events are connected to the use of inferior vena cava (IVC) filters to help prevent deep vein blood clots from developing into pulmonary embolisms (PE), according to the findings of the Predicting the Safety and Effectiveness of Inferior Vena Cava Filters (PRESERVE) trial, published jointly in the 


February 23, 2023 — Findings from a global study conducted by the American College of Cardiology (ACC) reveal that more than 1 in 4 cardiologists experience self-reported mental health conditions, or MHCs.


Subscribe Now